Edition:
United States

People: Catalyst Pharmaceuticals Inc (CPRX.O)

CPRX.O on Consolidated Issue listed on NASDAQ Capital Market

1.10USD
2 Dec 2016
Change (% chg)

$0.03 (+2.80%)
Prev Close
$1.07
Open
$1.08
Day's High
$1.10
Day's Low
$1.05
Volume
332,458
Avg. Vol
1,007,249
52-wk High
$3.00
52-wk Low
$0.51

Winship, M. Douglas 

Mr. M. Douglas Winship is the Vice President - Regulatory Operations of Catalyst Pharmaceutical Partners, Inc. Mr. Winship has worked in regulatory affairs and clinical operations in the biopharmaceutical industry for over 40 years. From 2004 to 2005, Mr. Winship was Vice President—Quality Assurance and Regulatory Affairs for Argos Therapeutics, Inc., a biotechnology company developing immunotherapy treatments for cancer, in Durham, North Carolina. Previously, Mr. Winship was employed by CEL-SCI Corp., a biotechnology company developing immune system based treatments, in Vienna, VA, from 1998 to 2002 as Senior Vice President—Regulatory Affairs and Quality Assurance, and from 1994 through 1998 as Vice President—Regulatory Affairs and Quality Assurance. From 1988 to 1994, Mr. Winship was employed by Curative Technologies, Inc., a health-care company involved in the wound-healing market, first as Director of Regulatory Affairs and Quality Assurance and later as Vice President of Regulatory Affairs and Quality Assurance. Mr. Winship earned his Bachelor of Science in chemistry from Upsala College.

Basic Compensation

Total Annual Compensation, USD 198,414
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 60,015
Fiscal Year Total, USD 258,429

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --